Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Current Leases: 2022-2024

Historic Current Leases for Caribou Biosciences (CRBU) over the last 3 years, with Dec 2024 value amounting to $1.4 million.

  • Caribou Biosciences' Current Leases rose 128.10% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 128.10%. This contributed to the annual value of $1.4 million for FY2024, which is 18.83% up from last year.
  • Per Caribou Biosciences' latest filing, its Current Leases stood at $1.4 million for FY2024, which was up 18.83% from $1.2 million recorded in FY2023.
  • In the past 5 years, Caribou Biosciences' Current Leases ranged from a high of $1.4 million in FY2024 and a low of $966,000 during FY2022.
  • Its 3-year average for Current Leases is $1.2 million, with a median of $1.2 million in 2023.
  • Data for Caribou Biosciences' Current Leases shows a peak YoY grew of 24.22% (in 2023) over the last 5 years.
  • Caribou Biosciences' Current Leases (Yearly) stood at $966,000 in 2022, then climbed by 24.22% to $1.2 million in 2023, then rose by 18.83% to $1.4 million in 2024.